Udvalget fulgte proceduren i artikel 107 i direktiv 2001/ 83/ EF, med senere ændringer, for lægemidler, der indeholder moxifloxacin i orale formuleringer.
The Committee considered the procedure under Article 107 of Directive 2001/ 83/ EC, as amended, for medicinal products containing moxifloxacin in oral formulations.